Anika to Participate in the Sidoti Virtual Investor Conference
Anika Therapeutics (NASDAQ: ANIK), a leader in osteoarthritis pain management and regenerative solutions, has announced its participation in the upcoming Sidoti Virtual Investor Conference. The company's management will deliver a virtual presentation followed by a Q&A session on Wednesday, May 21, 2025, at 1:00 PM ET. Investors can access the live webcast through Anika's Investor Relations website section at www.anika.com, where an archived version will also be available for later viewing.
Anika Therapeutics (NASDAQ: ANIK), leader nella gestione del dolore da osteoartrite e nelle soluzioni rigenerative, ha annunciato la sua partecipazione alla prossima Sidoti Virtual Investor Conference. Il management dell'azienda terrà una presentazione virtuale seguita da una sessione di domande e risposte mercoledì 21 maggio 2025 alle 13:00 ET. Gli investitori potranno accedere alla diretta streaming tramite la sezione Investor Relations del sito www.anika.com, dove sarà disponibile anche una versione registrata per la visione successiva.
Anika Therapeutics (NASDAQ: ANIK), líder en el manejo del dolor por osteoartritis y soluciones regenerativas, ha anunciado su participación en la próxima Sidoti Virtual Investor Conference. La dirección de la empresa realizará una presentación virtual seguida de una sesión de preguntas y respuestas el miércoles 21 de mayo de 2025 a la 1:00 PM ET. Los inversores podrán acceder a la transmisión en vivo a través de la sección de Relaciones con Inversores en www.anika.com, donde también estará disponible una versión archivada para su visualización posterior.
Anika Therapeutics (NASDAQ: ANIK)는 골관절염 통증 관리 및 재생 솔루션 분야의 선두주자로, 다가오는 Sidoti Virtual Investor Conference에 참여할 예정임을 발표했습니다. 회사 경영진은 2025년 5월 21일 수요일 오후 1시(동부시간)에 가상 프레젠테이션을 진행한 후 질의응답 시간을 가질 예정입니다. 투자자들은 www.anika.com의 투자자 관계 섹션을 통해 라이브 웹캐스트에 접속할 수 있으며, 이후 시청을 위한 녹화본도 제공됩니다.
Anika Therapeutics (NASDAQ : ANIK), leader dans la gestion de la douleur liée à l'arthrose et les solutions régénératives, a annoncé sa participation à la prochaine Sidoti Virtual Investor Conference. La direction de l'entreprise présentera une conférence virtuelle suivie d'une session de questions-réponses le mercredi 21 mai 2025 à 13h00 ET. Les investisseurs pourront accéder à la diffusion en direct via la section Relations Investisseurs du site www.anika.com, où une version enregistrée sera également disponible pour une consultation ultérieure.
Anika Therapeutics (NASDAQ: ANIK), ein führendes Unternehmen im Bereich der Schmerzbehandlung bei Osteoarthritis und regenerativer Lösungen, hat seine Teilnahme an der kommenden Sidoti Virtual Investor Conference angekündigt. Das Management des Unternehmens wird am Mittwoch, den 21. Mai 2025, um 13:00 Uhr ET eine virtuelle Präsentation halten, gefolgt von einer Fragerunde. Investoren können den Live-Webcast über den Investor-Relations-Bereich auf www.anika.com verfolgen, wo auch eine Aufzeichnung für die spätere Ansicht verfügbar sein wird.
- None.
- None.
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that management will participate in the Sidoti Virtual Investor Conference on Wednesday, May 21, 2025. Anika will host a virtual presentation with Q&A starting at 1:00pm ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is the global leader in the design, development, manufacturing, and commercialization of hyaluronic acid (“HA”) innovations. In partnership with clinicians, our sole focus is dedicated to delivering and advancing osteoarthritis (“OA”) pain management and orthopedic regenerative solutions. At our core is a passion to deliver a differentiated portfolio that improves patient outcomes around the world. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When is Anika Therapeutics (ANIK) presenting at the Sidoti Virtual Investor Conference?
How can investors watch Anika's (ANIK) Sidoti conference presentation?
What is Anika Therapeutics' (ANIK) main business focus?
Will there be a replay available of Anika's (ANIK) Sidoti conference presentation?
